IP Library Granted Patent US 9,988,623
Granted Patent B2
US 9,988,623 · App. 14/051,363 · Granted Jun 5, 2018

Methods of X-aptamer generation and compositions thereof

Inventors: David G Gorenstein (Houston, TX); Weiguo He (Pearland, TX); David E Volk (Dickinson, TX); Miguel-Angel Elizondo-Riojas (Houston, TX); Ross Durland (The Woodlands, TX); Johnnie Engelhardt (West Columbia, TX)
Assignees: AM Biotechnologies, LLC; Board of Regents of the University of Texas System
C12N15/1058C12N15/1048C12N15/115C12N2310/16C12N2310/315C12N2310/351C12N2320/11C12N2330/31
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,988,623
App. No.
14/051,363
Granted
Jun 5, 2018
Kind
B2
Abstract

Provided herein are methods for a novel bead-based next-generation “X-aptamer” selection scheme that extends aptamer technology to include X-modified bases, thus resulting in X-aptamers, at any position along the sequence because the aptamers are chemically synthesized via a split-pool scheme on individual beads. Also provides are application to a wide range of commonly used DNA modifications, including, but not limited to, monothioate and dithioate backbone substitutions. This new class of aptamer allows chemical modifications introduced to any of the bases in the aptamer sequence as well as the phosphate backbones and can be extended to other carbohydrate-based systems.

Claims (35)

1. A method for isolating a target specific X-aptamer comprising:

generating a primary one bead one unique oligonucleotide sequence library by a first split and pool bead synthesis using a programmed synthesizer;

identifying an aptamer lead sequence by target binding and sequence determination and pseudo-randomly inserting chemical linker modified nucleotides into the aptamer lead sequence by a second split and pool bead synthesis;

providing one or more X-ligands, wherein the X-ligands are known or predicted to bind to the target;

generating a secondary one bead one unique oligonucleotide sequence X-aptamer library using a second split and pool bead synthesis wherein the X-aptamer library is generated by adding the one or more X-ligands to the aptamer lead sequence and linking the one or more X-ligands via the chemical linkers that had been pseudo-randomly inserted into the aptamer lead sequence thereby forming an X-aptamer library; and

identifying a target specific X-aptamer sequence by target binding and sequence determination.

2. The method of claim 1 , wherein the primary one bead one unique oligonucleotide sequence library is partially thio-modified or dithio-modified.

3. The method of claim 1 , wherein one or more nucleotides are chemically modified in members of the primary one bead one unique oligonucleotide sequence library.

4. The method of claim 1 , wherein the secondary chemical linker modified one bead one unique oligonucleotide sequence X-aptamer library is partially thio-modified or dithio-modified.

5. The method of claim 1 , wherein the sequence determinations are performed by generation of unmodified oligonucleotide versions of the target binding sequences by polymerase chain reaction (PCR) amplification and nucleic acid sequencing.

6. The method of claim 1 , wherein the chemical linker containing base is 5-[N-(2-aminoethyl)-3-(E)-acrylamido]-2′-deoxyuridine.

7. The method of claim 1 wherein the X-ligands are attached to the chemical linker prior to creation of the oligonucleotide library.

8. The method of claim 1 wherein the X-ligands are attached to the chemical linker between split and pool steps during creation of the oligonucleotide library.

9. The method of claim 1 , wherein the X-ligands are coupled to the chemical linker after generation of the X-aptamer library.

10. The method of claim 1 , wherein the X-ligands are added to nucleotides that incorporate X-groups by click chemistry.

11. The method of claim 10 , wherein the X-ligands are added to nucleotides that incorporate ethynyl or azide X-groups by click chemistry.

12. The method of claim 1 , wherein the X-ligands are added to nucleotides that incorporate carboxyl groups for coupling chemistry.

13. The method of claim 1 , wherein the X-ligands are added to nucleotides that incorporate amine groups allowing for formation of an amide bond.

14. The method of claim 1 , wherein X-ligands are selected by one or more of: in silico screening, high-throughput chemical screening of target binding site interactions, and NMR.

15. A method for isolating a target specific X-aptamer comprising:

generating a primary one bead one unique oligonucleotide sequence library by a first split and pool bead synthesis using a programmed synthesizer;

identifying an aptamer lead sequence by target binding and sequence determination;

generating a secondary chemical linker modified one bead one unique oligonucleotide sequence X-aptamer library using a second split and pool bead synthesis wherein at least one chemical linker containing base is pseudo-randomly inserted into the aptamer lead sequence and one or more X-ligands are linked to the at least one chemical linker thereby forming an X-ligand linked X-aptamer library;

identifying a target specific X-aptamer sequence by target binding and sequence determination; and

optimizing the identified target specific X-aptamer sequence by trimming of sequences that are determined to be non-target binding.

16. A method for isolating a target specific X-aptamer comprising:

generating a primary one bead one unique oligonucleotide sequence library by a first split and pool bead synthesis using a programmed synthesizer;

identifying an aptamer lead sequence by target binding and sequence determination;

generating a secondary chemical linker modified one bead one unique oligonucleotide sequence X-aptamer library using a second split and pool bead synthesis wherein at least one chemical linker containing base is pseudo-randomly inserted into the aptamer lead sequence and one or more X-ligands are linked to the at least one chemical linker thereby forming an X-ligand linked X-aptamer library; and

identifying a target specific X-aptamer sequence by target binding and sequence determination, wherein the X-ligand is a small molecule selected by in silico screening to bind to the target.

17. A method for isolating a target specific X-aptamer comprising:

generating a primary one bead one unique oligonucleotide sequence library by a first split and pool bead synthesis using a programmed synthesizer;

identifying a lead sequence by target binding and sequence determination;

generating a secondary one bead one unique oligonucleotide sequence X-aptamer library using a second split and pool one bead synthesis, wherein at least one or more X-ligands selected from ligands that are known or thought to bind to the target are linked to the secondary one bead one unique oligonucleotide sequence X-aptamer library using a chemical linker pseudo-randomly inserted into the aptamer lead sequence that provides for attachment of one or more X-ligands in randomized positions into the lead sequence thereby forming a secondary X-ligand linked X-aptamer library; and

identifying a target specific X-aptamer sequence by target binding and sequence determination.

Assignments (5)
CONFIRMATORY LICENSE Recorded Jan 31, 2023
From: THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
To: NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR
Reel/Frame 062571/0253 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2018
From: GORENSTEIN, DAVID G.; HE, WEIGUO; VOLK, DAVID E.; ELIZONDO-RIOJAS, MIGUEL-ANGEL
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 045361/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2018
From: DURLAND, ROSS H.
To: AM BIOTECHNOLOGIES, LLC
Reel/Frame 045361/0244 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2018
From: ENGELHARDT, JOHNNIE
To: AM BIOTECHNOLOGIES, LLC
Reel/Frame 045361/0370 →
CONFIRMATORY LICENSE Recorded Jun 18, 2014
From: UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033192/0635 →
Continuity (2)
Provisional Application 61711915 · Oct 10, 2012
Related Publication 20140100120A1 · Apr 10, 2014